-+ 0.00%
-+ 0.00%
-+ 0.00%

BioRestorative to present new Phase 2 lumbar disc disease trial data at ISCT 2026

PUBT·04/30/2026 14:40:47
Listen to the news
BioRestorative to present new Phase 2 lumbar disc disease trial data at ISCT 2026
  • BioRestorative scheduled new safety and blinded efficacy data from its fully enrolled Phase 2 trial in chronic lumbar disc disease for presentation at ISCT 2026 in Dublin on May 6-9.
  • Update is positioned as a late-stage readout intended to show continued progress for BRTX-100 as a non-surgical option for patients with chronic disc-related lower back pain.
  • Separate preclinical findings on its MSC-derived exosome platform will be presented at same meeting, supporting plans to broaden its BioCosmeceutical pipeline.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioRestorative Therapies Inc. published the original content used to generate this news brief on April 30, 2026, and is solely responsible for the information contained therein.